Works matching IS 18696953 AND DT 2017 AND VI 8 AND IP 1
Results: 16
Costs of Managing Patients with Diabetes in a Large Health Maintenance Organization in Israel: A Retrospective Cohort Study.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 1, p. 167, doi. 10.1007/s13300-016-0212-9
- By:
- Publication type:
- Article
Intensification of IDegAsp Twice Daily (Adding Insulin Aspart vs. Switching To Basal-Bolus): Exploratory Randomized Trial in Type 2 Diabetes.
- Published in:
- 2017
- By:
- Publication type:
- Report
How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 1, p. 9, doi. 10.1007/s13300-016-0214-7
- By:
- Publication type:
- Article
Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 1, p. 149, doi. 10.1007/s13300-016-0215-6
- By:
- Publication type:
- Article
Erratum to: Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-Analysis.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 1, p. 85, doi. 10.1007/s13300-016-0217-4
- By:
- Publication type:
- Article
The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 1, p. 101, doi. 10.1007/s13300-016-0218-3
- By:
- Publication type:
- Article
Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 1, p. 129, doi. 10.1007/s13300-016-0219-2
- By:
- Publication type:
- Article
Lack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 1, p. 23, doi. 10.1007/s13300-016-0220-9
- By:
- Publication type:
- Article
Fear of Self-Injecting and Self-Testing and the Related Risk Factors in Adolescents with Type 1 Diabetes: A Cross-Sectional Study.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 1, p. 75, doi. 10.1007/s13300-016-0221-8
- By:
- Publication type:
- Article
Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 1, p. 177, doi. 10.1007/s13300-016-0222-7
- By:
- Publication type:
- Article
Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 1, p. 55, doi. 10.1007/s13300-016-0223-6
- By:
- Publication type:
- Article
GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 1, p. 115, doi. 10.1007/s13300-016-0224-5
- By:
- Publication type:
- Article
Insulin Degludec in Clinical Practice: A Review of Japanese Real-World Data.
- Published in:
- 2017
- By:
- Publication type:
- Report
Diabetes Distress or Major Depressive Disorder? A Practical Approach to Diagnosing and Treating Psychological Comorbidities of Diabetes.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 1, p. 1, doi. 10.1007/s13300-017-0231-1
- By:
- Publication type:
- Article
Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 1, p. 33, doi. 10.1007/s13300-016-0211-x
- By:
- Publication type:
- Article